Acura Pharmaceuticals has engaged Catalent Pharma Solutions to initiate manufacturing scale-up of LTX-03 (hydrocodone bitartrate and acetaminophen) tablets to ultimately be used in clinical testing. Formulation and manufacturing process optimization work being performed at a different laboratory is nearing completion.   LIMITx Technology is designed to retard the release of active drug ingredients when too many tablets are accidentally or purposefully ingested by neutralizing stomach acid with...